| Absorption |
| Blood-Brain Barrier | BBB+ | 0.6546 |
| Human Intestinal Absorption | HIA+ | 0.9942 |
| Caco-2 Permeability | Caco2+ | 0.7477 |
| P-glycoprotein Substrate | Substrate | 0.5297 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9523 |
| Non-inhibitor | 0.9381 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8967 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8757 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7351 |
| CYP450 2D6 Substrate | Non-substrate | 0.8971 |
| CYP450 3A4 Substrate | Non-substrate | 0.6694 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.9216 |
| CYP450 2C9 Inhibitor | Inhibitor | 0.8498 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.7178 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6800 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8146 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7417 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9434 |
| Non-inhibitor | 0.9109 |
| AMES Toxicity | AMES toxic | 0.9497 |
| Carcinogens | Non-carcinogens | 0.8769 |
| Fish Toxicity | High FHMT | 0.9655 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9844 |
| Honey Bee Toxicity | High HBT | 0.6915 |
| Biodegradation | Not ready biodegradable | 0.8205 |
| Acute Oral Toxicity | II | 0.4970 |
| Carcinogenicity (Three-class) | Non-required | 0.5154 |